Navigation Links
Leading AIDS Groups Turn Up The Heat on '08 Presidential Candidates
Date:11/28/2007

Website and new report unearth surprising responses on hot-button HIV/AIDS

issues Clinton, Edwards, Obama and Kucinich support ending ban on federal funds

for needle exchange

NEW YORK, Nov. 28 /PRNewswire-USNewswire/ -- Housing Works, Gay Men's Health Crisis (GMHC), and the AIDS Foundation of Chicago -- three of the nation's leading AIDS organizations -- polled 16 presidential hopefuls on pressing AIDS-related issues as part of an ongoing HIV/AIDS candidate and voter education campaign. Now the results are available on AIDSVote.org.

"World AIDS Day is this Saturday, but you could also say that World AIDS Day is Election Day 2008. That's because our next President will have the opportunity and the responsibility to end AIDS," said Charles King, President and CEO of Housing Works. "She or he will have the tools to treat 33 million people living with HIV-including over a million Americans-around the planet, as well as the tools to stop the spread of the virus. We're here to build the political will to make that happen."

"More than ever, the American public is calling for meaningful health care reform which includes bold leadership in the area of AIDS," said GMHC Chief Operating Officer Robert Bank. "Voters need to know what the candidates will do to fight AIDS when determining their readiness to be President."

The launch of AIDSVote.org, timed to coincide with World AIDS Day on December 1, features the results of the AIDSVote.org candidate questionnaire and Where Do They Stand? The Gay Men's Health Crisis Report on the 2008 Presidential Candidates and HIV/AIDS Issues, a detailed portrait of every candidate's history in public life on HIV/AIDS issues.

The AIDSVote.org website answers questions like "where does Rudy Giuliani stand on needle exchange funding?"; "will Sen. Barack Obama end federal support for ineffective and harmful abstinence-only education?"; and "
'/>"/>

SOURCE Gay Men's Health Crisis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
5. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
8. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.coman...scatalogue: ,, PainManagement-GlobalTrends ...anagement---Global-Trends.html ,, Widespreadav...clinics,andtheadventofnewdrugshaveacceleratedthepa...rmsandreimbursementstructurecontinuetoshapedemandf...
(Date:11/25/2009)..., MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- Chem...ldatafromtheCompany,sPROTECT-1(theProspectiveRando...Traficet-EN(TM)(CCX282-B)inpatientswithmoderate-to...ithafavorablesafetyandtolerabilityprofile.Thestudy...onofdiseaseseverityasdefinedasa70-pointdecreaseint...
(Date:11/24/2009)..., MADISON,N.J.,Nov.24/PRNewswire-FirstCall/--Que...adingproviderofdiagnostictesting,informationandser...nualPiperJaffrayHealthcareConferenceinNewYorkCity....009at9:30a.m.EasternTime. ,, Duringtheconferenc...rowthtoapproximate3%,operatingincometoexceed18%ofr...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2New method separates cancer cells from normal cells 8842 1New method separates cancer cells from normal cells 8842 2Pelosi Statement on President Obamas Speech to AMA on Urgent Need for Health Care Reform 48948 1American Hospital Management Company Announces the Opening of the New HOSPITAL UNIVERSITARIO DEL RIO HOSPIRIO in Cuenca Ecuador 48945 1American Hospital Management Company Announces the Opening of the New HOSPITAL UNIVERSITARIO DEL RIO HOSPIRIO in Cuenca Ecuador 48945 2
..." Study Also Showed Arzoxifene Significantly Suppr...ostmenopausal Women with Osteoporosis , , ATHENS,...LLY ) presented new data showing arzoxifene, an in...r (SERM), was superior to raloxifene at increasing...otal hip and femoral neck, and at suppressing bone...
...20 Santaris Pharma announced today that,the fourt... In the USA,several patients with cancer have now ..., which is jointly developed by Santaris Pharma an...ministration (FDA) recently,accepted Enzon PharmaÂ...tion,for the use of the LNA-based Survivin inhibit...
Other Medicine Technology:Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 2Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 3Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 4Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 5Another LNA-based RNA Inhibitor Enters Clinical Trials 2Another LNA-based RNA Inhibitor Enters Clinical Trials 3
(Date:11/25/2009)...swire/--TheBlackAIDSInstituterecentlyheldBoardofDi...10. ,, ThenewBoardMembersareahighlydiversegroup...,governmenthealthprograms,editorial,andbusinessent...sonalbackgroundsincludingbothheterosexualandgayBla...sentingmultipleagegroups. ,, (Photo: http://www...
(Date:11/25/2009)...ss,andPressJoinEfforttoEducate ,, MEMPHIS,Tenn...onalBipolarFoundationandtheMedicAlertFoundationrec...gram,whichisnowbeingwidelyacceptedasapreventivehea...BipolarFoundationreceivedaproclamationofendorsemen...LouisianaMitchLandrieu.TheNationalBipolarFoundatio...
(Date:11/25/2009)...tistically significant survival benefit from adjuv...or (ER)-positive tumors had high levels of phospho...-P), according to a brief communication published ... Cancer Institute . , Approximately 50% of breas...al studies have shown that ER-alpha S118-P is requ...
(Date:11/25/2009)...is simple question has been the focus of intense r...odulates High Blood Pressure in Mice & Men, Does ...ion has been the focus of intense research for man...established a link between a novel gene, phosducin...e as well as humans. The studies were directed by ...
(Date:11/25/2009)...d arthritis, could help newly diagnosed diabetics,...lthDay News) -- A drug commonly used to treat non-...so shows some promise in helping patients newly di...imab (Rituxan), helped patients keep producing som...d destroyed some of their pancreatic beta cells, w...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...ew study in the July issue of Archives of General ...nd are in fact more prone to depression. //The stu...ons were at a 25 percent increased risk of develop... issue because both of these conditions are so com...
...nting fears of an avian flu outbreak has caused Au... face masks. // Pandemic risk committees in co...ublic companies such as Bluescope Steel and Telstr...he event of an outbreak have been included in the ...
...is believed that menopause plays a role in the los... result in an accelerated loss of muscle //mass an...ssouri-Columbia researcher studied the effect of i...beth Brown, professor of physical therapy in MU’s ...
...ingle pill which combines three drugs is the compl...the pill daily to keep the virus that causes the d...ot come to the market and is expected to hit the m...s a day about 11 years ago and expects to switch t...
...am government will write to All Indian Medical Cou...o post graduate courses in Assam Medical College H...iswa Sarma today said. He told reporters here...or of All India Medical Entrance Examination that ...
...tudy conducted at University of Colorado has revea...th prostate cancer do not assimilate the informati...obviously not aware of the potential risks and tre... own anxieties that blocks their thinking and even...
Other Medicine News:Health News:Australian Businesses Prepare for Outbreak of Bird Flu 2Health News:Muscles May Need Estrogen to Regain Strength, Especially as Women Age 2Health News:The New AIDS Pill 2
Eppendorf Research Series 2100 Fixed-volume Pipette, 100 l
Finnpipette Fixed Volume, 20ul
Pipetman F1000
Finnpipette Focus Fixed Volume, 1ul
Medicine Products: